BioSpace News Archive

Samantha Castellanos-Santana was delivered at 30 weeks gestation and was born with an opening in her heart, a condition known as patent ductus arteriosus.

Today, the U.S. Food and Drug Administration authorized the first diagnostic test for at home collection of patient samples to detect both COVID-19 and influenza A and B (flu). The FDA authorized Quest Diagnostics RC COVID-19 +Flu RT-PCR Test for prescription use with the Quest Diagnostics Self-Collection Kit for COVID-19 +Flu

RICHMOND HILL, ON / ACCESSWIRE / December 4, 2020 / Helix BioPharma Corp. ( TSX:HBP ) (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced it has closed a private placement financing for gross proceeds of $1,100,000. The terms of the placement are for the purchase of units at $0.50 per unit. Each unit is comprised of one com

Saxenda® (liraglutide) injection 3 mg becomes the first FDA-approved therapy to treat obesity in adolescents in more than a decade

Biocom California, the association representing the California life science industry, joined the Biotechnology Innovation Organization and the California Life Sciences Association in filing a challenge against the Department of Health and Human Services’ recent Most-Favored Nation Interim Final Rule.